There is broad consensus that the overall body of evidence shows lowering LDL (low-density lipoprotein) cholesterol provides ...

The exact role of different types of dietary fat and the best approach to prevention in cardiovascular disease has been ...

Nonprescription rosuvastatin pans out in a second trialThe TACTiC study included 1,196 participants (median age 63, 39.6% women) who completed the web app assessment and got the OK to use statins ...

Among the 3,157 patients aged 80 years and older, compared with those who had a statin prescription of less than 2 years or none at all, those who had a statin prescription for 2 years had lower ...

Medscape interviewed Peter Sever, Co-Chair of ASCOT, about putting to rest the idea that reducing C-reactive protein with a statin has any cardiovascular benefits beyond lowering LDL cholesterol.

Concomitant use of statins improved survival among people with cancer treated with immune checkpoint inhibitors, according to results of a meta-analysis. “These findings highlight the potential ...

The outcomes of interest were the drug's acceptability, tolerability, and efficacy. The researchers measured acceptability as the ratio of discontinuations (due to any cause) from initiation of ...

METHODOLOGY: Previous studies have shown the efficacy of inclisiran in lowering the level of LDL cholesterol when used in combination with statins in patients with a high risk for atherosclerosis ...

Statin-intolerant patients were also eligible for the study. Evolocumab-treated patients who completed the 24-week double-blind treatment period were enrolled in an open-label period through the ...